WAIVER REGARDING ANTI-DILUTION May __, 2014Waiver Regarding Anti-Dilution • August 12th, 2014 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 12th, 2014 Company IndustryReference is hereby made to that certain Warrant issued to [________] ("[WARRANTHOLDER]") by Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), pursuant to the Underwriting Agreement, dated as of August 13, 2013, by and among the Company, Roth Capital Partners, LLC and Maxim Group LLC (the “Warrant”), as set forth on Schedule 1 attached hereto. Capitalized terms not defined herein shall have the meaning assigned to such terms in the Warrant.